Indrayani Biotech Limited

INDRANIB6

INE007C01021

Hotels, Motels & Cruise Lines

Market Closed - Bombay S.E. Other stock markets 11:00:56 14/06/2024 BST			5-day change	1st Jan Change
52.73 ^INR	+5.00%		+10.01%	-16.53%

05-30	Indrayani Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-10	Indrayani Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Indrayani Biotech Limited Appoints Muthu Krishnan Ramesh as Additional Director

January 04, 2021 at 11:11 am

Indrayani Biotech Limited announced the appointment of Muthu Krishnan Ramesh as additional director of the company under section 161 of companies act, 2013, at the board meeting held on January 4, 2021.

Latest news about Indrayani Biotech Limited

Indrayani Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-30	CI
Indrayani Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-10	CI
Indrayani Biotech Limited Announces Company Secretary & Compliance Officer Changes	01-10	CI
Indrayani Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Indrayani Biotech Limited Approves Borrowing of Funds from the Banks and Financial Institutions	22/09/23	CI
Indrayani Biotech Unit Acquires Vaasan Medical Center	28/08/23	MT
Indrayani Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23	CI
Indrayani Biotech's Consolidated Net Profit Drops in Fiscal Q4	15/06/23	MT
Indrayani Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	14/06/23	CI
Indrayani Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	14/06/23	CI
Indrayani Biotech Limited Appoints Rajesh Kumar Sundarray as New Company Secretary Cum Compliance Officer	11/05/23	CI
Indrayani Biotech Limited Announces Executive Changes	11/05/23	CI
Indrayani Biotech to Acquire 51% of Indian Pharmaceutical Company KNISS Laboratories	14/04/23	MT
Indrayani Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Indrayani Biotech Bags Contract for Food Supply from Gautam Buddha University in India	03/01/23	MT
Indrayani Biotech Limited Announces Executive Changes	10/12/22	CI
Indrayani Biotech Arm Acquires 51% Stake in Pharma Marketing Company	08/12/22	MT
Indrayani Biotech Limited acquired 51% stake in Matrix Boilers Private Limited for INR2.8 million.	13/11/22	CI
Southern Railways Empanel Indrayani Biotech Limited for Design, Manufacture and Supply of Industrial Boilers	01/11/22	CI
Indrayani Biotech Forms New Subsidiary for Social Welfare Activities	13/09/22	MT
Indrayani Biotech Limited Incorporates Subsidiary	12/09/22	CI
Indrayani Biotech Bags Catering Services Contract Worth $1.5 Million	22/08/22	MT
Indrayani Biotech Forms New Wholly-Owned Subsidiary	26/05/22	MT
Indrayani Biotech Limited announced that it has received INR 235.16798 million in funding	08/05/22	CI
Indrayani Biotech Limited Approves Constitution the Allotment Committee	06/05/22	CI

Chart Indrayani Biotech Limited

Duration

Period

More charts

Company Profile

Indrayani Biotech Limited is an India-based company, which is engaged in the business of food and hospitality, dairy, healthcare and pharmaceutical (pharma), engineering, biotechnology (biotech), agriculture, and infrastructure. The Company's food and hospitality business provides food supply services on a contract basis to colleges and universities, corporate offices and others. Its dairy business products include evaporated milk and whey powder. Its healthcare and pharma business manufactures pharma and operates pharma retail chains. The Company also operates hospitals and clinics. Its engineering business designs, engineers and manufactures waste heat recovery systems, such as package boilers and steam drums. Its biotech business products include micro-organisms-based bio-fertilizers and bio-pest controllers. Its agriculture business includes corporate farming on its own farms and additional land taken on lease. It promotes commercial and residential infrastructure projects.

Sector

Hotels, Motels & Cruise Lines

Calendar

11/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Hotels & Motels

	1st Jan change	Capi.
INDRAYANI BIOTECH LIMITED	-16.53%	28.74M
H WORLD GROUP LIMITED	+2.03%	10.71B
WHITBREAD PLC	-20.95%	6.68B
WYNDHAM HOTELS & RESORTS, INC.	-10.15%	5.82B
CHOICE HOTELS INTERNATIONAL, INC.	+1.80%	5.51B
SHANGHAI JIN JIANG INTERNATIONAL HOTELS CO., LTD.	-10.70%	3.58B
SHANGRI-LA ASIA LIMITED	+4.10%	2.49B
ATOUR LIFESTYLE HOLDINGS LIMITED	-1.61%	2.35B
MANDARIN ORIENTAL INTERNATIONAL LIMITED	+17.31%	2.31B
CHALET HOTELS LIMITED	+18.66%	2.16B

Hotels & Motels